| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |